drugs with the potential
qtc interval
torsades de pointes-type arrhythmias
sudden death
cardiovascular
side effects
hypotension
tachycardia
mesoridazine
qtc interval in a dose
related manner
central
nervous system
side effects
drowsiness
parkinson
syndrome
dizziness
weakness
tremor
restlessness
ataxia
dystonia
rigidity
slurring
akathisia
motoric reactions
opisthotonos
autonomic nervous system effects
dry mouth
nausea
vomiting
fainting
stuffy nose
photophobia
constipation
vision
adverse effects
rigidity
motoric effects
therapy
genitourinary side effects
inhibition of ejaculation
impotence
enuresis
incontinence
priapism
dermatologic side effects
itching
rash
hypertrophic papillae of the tongue
angioneurotic edema
side effects of serentil
fda
healthcare professional for medical advice